Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ductal carcinoma in situ in BRCA mutation carriers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Feb 2007

Hwang E Shelley, McLennan Jane L, Moore Dan H, Crawford Beth B, Esserman Laura J, Ziegler John L

Abstract excerpt

PURPOSE: The current literature suggests that ductal carcinoma in situ (DCIS) of the breast is infrequently diagnosed in patients with BRCA germline mutations. We studied women at high risk of hereditary breast cancer syndromes who underwent testing for BRCA1 and BRCA2 to estimate DCIS prevalence and incidence in known BRCA-positive women compared with high-risk women who were mutation negative. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Survival Analysis
Share to Proportional Hazards Models

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Age Distribution

Share to Carcinoma, Intraductal, Noninfiltrating

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Neoplasm Staging

Share to Probability

Source

Identifiers

PMID: 17210933
DOI: 10.1200/JCO.2005.04.0345

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ductal carcinoma in situ in BRCA mutation carriers.PMID 17210933Read ↗

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.Semantic proximity Read ↗

BRCA mutations in women with ductal carcinoma in situ.Semantic proximity Read ↗

Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers.Semantic proximity Read ↗

The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.Semantic proximity Read ↗

Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast.Semantic proximity Read ↗

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 yearsSemantic proximity Read ↗

Genetic risk variants associated with in situ breast cancer.Semantic proximity Read ↗

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers.Semantic proximity Read ↗

Genetic predisposition to ductal carcinoma in situ of the breast.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.Semantic proximity Read ↗

DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.